Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?
University of Minnesota, Minneapolis, USA. mille011@umn.edu
Jeffrey S
JS
Miller
D018929:Cell Culture Techniques; D049109:Cell Proliferation; D003602:Cytotoxicity, Immunologic; D016219:Immunotherapy, Adoptive; D019409:Interleukin-15 / Q000276:immunology / Q000378:metabolism; D007376:Interleukin-2 / Q000276:immunology / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D009369:Neoplasms / Q000628:therapy*
D019409:Interleukin-15; D007376:Interleukin-2